Dr. Daniel Young, MD

Dr. Young practices at Infectious Disease Specialists of Northwest Arkansas in Fayetteville, Arkansas.

Dr. Young's NPI, 1265656425, was assigned on April 12, 2007. Dr. Young holds Arkansas license E-5498.

Dr. Young's primary practice is Infectious Disease Specialists of Northwest Arkansas, at 4038 N Remington Dr, Fayetteville, AR 72703 in Washington County. The practice phone is (479) 444-6522.

Dr. Young's primary practice is Infectious Disease Specialists of Northwest Arkansas in Fayetteville, Arkansas. Dr. Young is also affiliated with Washington Regional Medical Center. The medical group on file is Infectious Disease Specialists of Northwest Arkansas. Dmand AI also links Dr. Young to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Young is licensed in Arkansas.

CMS data shows 976 Medicare services from Dr. Young across 10 procedure codes in 2024, for 334 Medicare patients. Medicare paid $73,630 for them.

CMS counts 334 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 65, with 46% women.

In 2024, Dr. Young wrote 1,123 Medicare Part D claims for 201 patients. 73% of them were for generic drugs. CMS names the drug for 1,064 of them, across 31 drugs with 11 or more claims each, at $1,321,857 in total drug cost. In 2023, CMS named 1,182 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Young for performance year 2024, reported as part of a group. Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 654 general payments to Dr. Young from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Gilead Sciences, Inc. paid the most, $58,045.